Triveni Bio raises $65M ahead of upcoming readouts on eczema drugsnews2026-06-17T11:00:11+00:00June 17th, 2026|Endpoints News|
Migraine biotech Vedana Therapeutics makes its debut with $46M Series Anews2026-06-17T09:00:18+00:00June 17th, 2026|Endpoints News|
Breakdown product of pesticides and refrigerants may be classed as reproductive toxicant by EUnews2026-06-17T08:30:00+00:00June 17th, 2026|Chemistry World|
